Using period analysis to timely provide serial data on long-term survival for patients with hematological malignancies from Taizhou, Eastern China - Summary - MDSpire
Advertisement
Using period analysis to timely provide serial data on long-term survival for patients with hematological malignancies from Taizhou, Eastern China
To investigate the long-term survival outcomes of common hematological malignancies (HMs) in a Chinese population using period analysis.
Key Findings:
The overall 5-year RS for all HMs was 57.0%.
Lymphoma had the highest 5-year RS at 64.4%, followed by multiple myeloma (51.1%) and leukemia (49.3%).
10-year and 15-year RS decreased to 46.0% and 37.5%, respectively.
Females had higher RS than males, except for leukemia.
Patients aged <60 years had significantly higher RS than those aged ≥60 years.
Urban areas showed higher RS compared to rural areas.
The median age at diagnosis was 62 years.
Interpretation:
The study provides critical insights into long-term survival rates of HMs in Taizhou, highlighting disparities based on age, sex, and region, which can inform public health strategies.
Limitations:
Data limited to a specific region (Taizhou) and may not be generalizable to other areas.
Potential biases in data collection and follow-up methods may affect the results.
Conclusion:
This study is the first to present comprehensive long-term survival data for HMs in Taizhou, offering essential evidence for optimizing cancer control measures and informing public health strategies.
